Clayton A. Smith

Cincinnati Children's Hospital Medical Center

Also affiliated with The Medical Center of Aurora, University of Colorado Anschutz Medical Campus

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells”.

Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells

Nature Cancer(2020)10.1038/s43018-020-00126-z

N/A

7.2DataRank · unranked

315 citations

Courtney L. Jones, Daniel A. Pollyea, Rachel Culp‐Hill, Angelo D’Alessandro, Amanda Winters +11 more

Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells

Cell stem cell(2020)10.1016/j.stem.2020.07.021

N/A

6.2DataRank · unranked

232 citations

Brett M. Stevens, Daniel A. Pollyea, Rachel Culp‐Hill, Julie A. Reisz, Travis Nemkov +17 more

A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.04.519036

N/A

0DataRank · unranked

12 citations

Austin E. Gillen, Ian T. Shelton, Brett M. Stevens, Maura Gasparetto, Krysta L. Engel +17 more

A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1297

N/A

0DataRank · unranked

100 citations

Ian T. Shelton, Austin E. Gillen, Brett M. Stevens, Maura Gasparetto, Yanan Wang +20 more

Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium

Cancer Discovery(2024)10.1158/2159-8290.cd-23-1145

N/A

0DataRank · unranked

33 citations

Mark J. Althoff, Hunter Tolison, Krysta L. Engel, Maria L. Amaya, Anna E. Krug +19 more

Dominantly acting variants in ATP6V1C1 and ATP6V1B2 cause a multisystem phenotypic spectrum by altering lysosomal and/or autophagosome function

Human Genetics and Genomics Advances(2024)10.1016/j.xhgg.2024.100349

N/A

0DataRank · unranked

8 citations

Serena Cecchetti, Gianfranco Bocchinfuso, Francesca Clementina Radio, Chiara Leoni, Roberta Onesimo +30 more

Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia

Haematologica(2024)10.3324/haematol.2023.284716

N/A

0DataRank · unranked

5 citations

Amanda Winters, Haobin Ye, Shanshan Pei, Brett Stevens, Austin E. Gillen +18 more

Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia

Cancer Discovery(2020)10.1158/2159-8290.cd-19-0710

N/A

0DataRank · unranked

555 citations

Daniel A. Pollyea, Annika Gustafson, Brett M. Stevens, Mohammad Minhajuddin, Rui Fu +27 more

Therapy resistance in AML is mediated by cytoplasmic sequestration of the transcriptional repressor IRF2BP2

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.22.655396

N/A

0DataRank · unranked

0 citations

Mohd Minhajuddin, Brett M. Stevens, Austin E. Gillen, Stephanie Gipson, Sweta B. Patel +17 more

Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progression

Blood Advances(2020)10.1182/bloodadvances.2019000122

N/A

0DataRank · unranked

24 citations

Michael J. VanWyngarden, Brett M. Stevens, Diana Abbott, Andrew Hammes, Christophe Langouët-Astrié +7 more